DAVID J WOODHOUSE
CIK 1642995 · Chief Executive Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
14
Lifetime Open-Market Net
-$300.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRZNW | Director | — | $0.02 | — | $0 | 5 | 2026-05-14 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Chief Executive Officer | 0 | $1.54 | $0 | -$300.3K | 9 | 2024-04-08 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-30 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Exer (M) | +17,654 | $138.0K | EDGAR |
| 2021-11-19 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Mixed | — | -$187.2K | EDGAR |
| 2021-03-18 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-06 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.